Role of the human erythrocyte in generation and storage of asymmetric dimethylarginine

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 302, Issue 8, 2012, Pages

  Davids, Mariska ^a   van Hell, Albert J ^a   Visser, Marlieke ^a,b   Nijveldt, Robert J ^a   van Leeuwen, Paul A M ^a   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Critical illness; Proteasome; Proteolytic degradation; Red blood cells

Indexed keywords

HEMOGLOBIN; N(G),N(G) DIMETHYLARGININE; PROTEASOME; PROTEINASE;

ADULT; AGED; ARTICLE; CELL LINE; CELL LYSATE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; CYTOLYSIS; ENZYME ACTIVITY; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; FEMALE; HUMAN; HUMAN CELL; INCUBATION TEMPERATURE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECRETION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; ARGININE; BIOLOGICAL TRANSPORT; BLOOD PROTEINS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRITICAL ILLNESS; ERYTHROCYTES; FEMALE; HUMANS; HYDROLYSIS; MALE; MIDDLE AGED; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; SOLID PHASE EXTRACTION; YOUNG ADULT;

EID: 84859762686     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01205.2011     Document Type: Article

References (66)

1. Agli AN, Schaefer A, Geny B, Piquard F, Haberey P. Erythrocytes participate significantly in blood transport of amino acids during the post absorptive state in normal humans. Eur J Appl Physiol Occup Physiol 78: 502-508, 1998.
2. Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res 43: 521-531, 1999.
3. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell 33: 1-13, 2009.
4. Billecke SS, Kitzmiller LA, Northrup JJ, Whitesall SE, Kimoto M, Hinz AV, D'Alecy LG. Contribution of whole blood to the control of plasma asymmetrical dimethylarginine. Am J Physiol Heart Circ Physiol 291: H1788-H1796, 2006.
5. Billecke SS, D'Alecy LG, Platel R, Whitesall SE, Jamerson KA, Perlman RL, Gadegbeku CA. Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease. Nephrol Dial Transplant 24: 489-496, 2009.
6. Böger RH, Maas R, Schulze F, Schwedhelm E. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality-An update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60: 481-487, 2009.
7. Böhmer A, Beckmann B, Sandmann J, Tsikas D. Doubts concerning functional endothelial nitric oxide synthase in human erythrocytes. Blood 119: 1322-1323, 2012.
8. Bröer S, Palacín M. The role of amino acid transporters in inherited and acquired diseases. Biochem J 436: 193-211, 2011.
9. Brunini TM, Roberts NB, Yaqoob MM, Ellory JC, Mann GE, Mendes Ribeiro AC. Activation of L-arginine transport in undialysed chronic renal failure and continuous ambulatory peritoneal dialysis patients. Clin Exp Pharmacol Physiol 33: 114-118, 2006.
10. Bussolati O, Laris PC, Nucci FA, Dall'Asta V, Longo N, Guidotti GG, Gazzola GC. Dependence of L-arginine accumulation on membrane potential in cultured human fibroblasts. Am J Physiol Cell Physiol 253: C391-C397, 1987.
11. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 213: 67-77, 2006.
12. D'Alecy LG, Billecke SS. Massive quantities of asymmetric dimethylarginine (ADMA) are incorporated in red blood cell proteins and may be released by proteolysis following hemolytic stress. Blood Cells Mol Dis 45: 40, 2010.
13. da Costa BP, Steibel JP, Antonello IC, Guimarães JA, Poli de Figueiredo CE. L-Arginine erythrocyte transport in normal pregnant and preeclamptic women. Am J Obstet Gynecol 190: 468-471, 2004.
14. De Jong S, Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 353: 287-289, 2006.
15. Devés R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 78: 487-545, 1998.
16. Divino Filho JC, Bárány P, Stehle P, Fürst P, Bergström J. Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients. Nephrol Dial Transplant 12: 2339-2348, 1997.
17. Flügel-Link RM, Jones MR, Kopple JD. Red cell and plasma amino acid concentrations in renal failure. JPEN J Parenter Enteral Nutr 7: 450-456, 1983.
18. Förstermann U. Nitric oxide and oxidative stress in vascular disease. Pflügers Arch 459: 923-939, 2010.
19. Gladwin MT, Crawford JH, Patel RP. The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation. Free Radic Biol Med 36: 707-717, 2004.
20. Goodman SR, Kurdia A, Ammann L, Kakhniashvili D, Daescu O. The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 232: 1391-1408, 2007.
21. Hallemeesch MM, Soeters PB, Deutz NE. Tracer methodology in whole body and organ balance metabolic studies: plasma sampling is required. A study in post-absorptive rats using isotopically labeled arginine, phenylalanine, valine and leucine. Clin Nutr 19: 157-163, 2000.
22. Hanssen H, Brunini TM, Conway M, Banning AP, Roberts NB, Mann GE, Ellory JC, Mendes Ribeiro AC. Increased L-arginine transport in human erythrocytes in chronic heart failure. Clin Sci (Lond) 94: 43-48, 1998.
23. Jay AW, Burton AC. Direct measurement of potential difference across the human red blood cell membrane. Biophys J 9: 115-121, 1969.
24. Kang ES, Cates TB, Harper DN, Chiang TM, Myers LK, Acchiardo SR, Kimoto M. An enzyme hydrolyzing methylated inhibitors of nitric oxide synthase is present in circulating human red blood cells. Free Radic Res 35: 693-707, 2001.
25. Kato GJ, Wang Z, Machado RF, Blackwelder WC, Taylor JG, Hazen SL. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol 145: 506-513, 2009.
26. Kielstein JT, Böger RH, Bode-Böger SM, Martens-Lobenhoffer J, Lonnemann G, Frölich JC, Haller H, Fliser D. Low dialysance of asymmetric dimethylarginine (ADMA)-in vivo and in vitro evidence of significant protein binding. Clin Nephrol 62: 295-300, 2004.
27. Kielstein JT, Böger RH, Bode-Böger SM, Schäffer J, Barbey M, Koch KM, Frölich JC. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J Am Soc Nephrol 10: 594-600, 1999.
28. Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, Hoeper MM, Haller H, Fliser D. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109: 172-177, 2004.
29. Kielstein JT, Zoccali C. Asymmetric dimethylarginine: a cardiovascular risk factor and a uremic toxin coming of age? Am J Kidney Dis 46: 186-202, 2005.
30. Klaude M, Fredriksson K, Tjäder I, Hammarqvist F, Ahlman B, Rooyackers O, Wernerman J. Proteasome proteolytic activity in skeletal muscle is increased in patients with sepsis. Clin Sci (Lond) 112: 499-506, 2007.
31. Kurbel S. Donnan effect on chloride ion distribution as a determinant of body fluid composition that allows action potentials to spread via fast sodium channels. Theor Biol Med Model 8: 16, 2011.
32. Landburg PP, Teerlink T, Biemond BJ, Brandjes DP, Muskiet FA, Duits AJ, Schnog JB. Plasma asymmetric dimethylarginine concentrations in sickle cell disease are related to the hemolytic phenotype. Blood Cells Mol Dis 44: 229-232, 2010.
33. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 7: 156-167, 2008.
34. Mendes Ribeiro AC, Brunini TM, Ellory JC, Mann GE. Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 49: 697-712, 2001.
35. Mendes Ribeiro AC, Hanssen H, Kiessling K, Roberts NB, Mann GE, Ellory JC. Transport of L-arginine and the nitric oxide inhibitor NGmonomethyl- L-arginine in human erythrocytes in chronic renal failure. Clin Sci (Lond) 93: 57-64, 1997.
36. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 147: S193-201, 2006.
37. Morimoto H, Nakao K, Fukuoka K, Sarai A, Yano A, Kihara T, Fukuda S, Wada J, Makino H. Long-term use of vitamin E-coated polysulfone membrane reduces oxidative stress markers in haemodialysis patients. Nephrol Dial Transplant 20: 2775-2782, 2005.
38. Morris SM Jr. Arginine metabolism in vascular biology and disease. Vasc Med 10, Suppl 1: S83-S87, 2005.
39. Neelam S, Kakhniashvili DG, Wilkens S, Levene SD, Goodman SR. Functional 20S proteasomes in mature human red blood cells. Exp Biol Med (Maywood) 236: 580-591, 2011.
40. Nijveldt RJ, Teerlink T, Siroen MP, Van Lambalgen AA, Rauwerda JA, Van Leeuwen PA. The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA). Clin Nutr 22: 17-22, 2003.
41. Nijveldt RJ, Teerlink T, Van der Hoven B, Siroen MP, Kuik DJ, Rauwerda JA, Van Leeuwen PA. Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin Nutr 22: 23-30, 2003.
42. Nijveldt RJ, Teerlink T, Van Guldener C, Prins HA, Van Lambalgen AA, Stehouwer CD, Rauwerda JA, Van Leeuwen PA. Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18: 2542-2550, 2003.
43. Nijveldt RJ, Teerlink T, Van Leeuwen PA. The asymmetrical dimethylarginine (ADMA)-multiple organ failure hypothesis. Clin Nutr 22: 99- 104, 2003.
44. Nijveldt RJ, Van Leeuwen PA, Van Guldener C, Stehouwer CD, Rauwerda JA, Teerlink T. Net renal extraction of asymmetrical (ADMA) and symmetrical (SDMA) dimethylarginine in fasting humans. Nephrol Dial Transplant 17: 1999-2002, 2002.
45. Pacifici RE, Salo DC, Davies KJ. Macroxyproteinase (MOP): a 670 kDa proteinase complex that degrades oxidatively denatured proteins in red blood cells. Free Radic Biol Med 7: 521-536, 1989.
46. Palm F, Onozato ML, Luo Z, Wilcox CS. Dimethylarginine imethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal ystems. Am J Physiol Heart Circ Physiol 293: H3227-H3245, 2007.
47. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108: 791-801, 2006.
48. Richir MC, Bouwman RH, Teerlink T, Siroen MP, de Vries TP, Van Leeuwen PA. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. JPEN J Parenter Enteral Nutr 32: 613-621, 2008.
49. Roth GA, Moser B, Krenn C, Roth-Walter F, Hetz H, Richter S, Brunner M, Jensen-Jarolim E, Wolner E, Hoetzenecker K, Boltz- Nitulescu G, Ankersmit HJ. Heightened levels of circulating 20S proteasome in critically ill patients. Eur J Clin Invest 35: 399-403, 2005.
50. Schnog JB, Teerlink T, Van der Dijs FP, Duits AJ, Muskiet FA. Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. Ann Hematol 84: 282-286, 2005.
51. Siroen MP, Teerlink T, Bolte AC, Van Elburg RM, Richir MC, Nijveldt RJ, Van der Hoven B, Van Leeuwen PA. No compensatory upregulation of placental dimethylarginine dimethylaminohydrolase activity in preeclampsia. Gynecol Obstet Invest 62: 7-13, 2006.
52. Siroen MP, Teerlink T, Nijveldt RJ, Prins HA, Richir MC, Van Leeuwen PA. The clinical significance of asymmetric dimethylarginine. Annu Rev Nutr 26: 203-228, 2006.
53. Siroen MP, Van der Sijp JR, Teerlink T, Van Schaik C, Nijveldt RJ, Van Leeuwen PA. The human liver clears both asymmetric and symmetric dimethylarginine. Hepatology 41: 559-565, 2005.
54. Tamura N, Lottspeich F, Baumeister W, Tamura T. The role of tricorn protease and its aminopeptidase-interacting factors in cellular protein degradation. Cell 95: 637-648, 1998.
55. Teerlink T. ADMA metabolism and clearance. Vasc Med 10, Suppl 1: S73-S81, 2005.
56. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: Regulation and action. Pharmacol Res 60: 448-460, 2009.
57. Teerlink T, Nijveldt RJ, De Jong S, Van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 303: 131-137, 2002.
58. Teerlink T, Van Leeuwen PA, Houdijk AP. Plasma amino acids determined by liquid chromatography within 17 minutes. Clin Chem 40: 245-249, 1994.
59. Tsikas D, Beckmann B. Albumin from human serum does not contain asymmetric dimethylarginine (ADMA). Clin Biochem 42: 1739-1740, 2009.
60. Tsikas D, Engeli S, Beckmann B, Jordan J. Asymmetric dimethylarginine (ADMA) is present in plasma proteins of healthy subjects at the low nmol-per-g-level. Nitric Oxide 22: 316-317, 2010.
61. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575, 1992.
62. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22: 707-710, 1996.
63. Visser M, Paulus WJ, Vermeulen MA, Richir MC, Davids M, Wisselink W, de Mol BA, Van Leeuwen PA. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 12: 1274-1281, 2010.
64. Wilcken DE, Sim AS, Wang J, Wang XL. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. Mol Genet Metab 91: 309-317, 2007.
65. Zinellu A, Sotgia S, Scanu B, Deiana L, Carru C. Determination of protein-incorporated methylated arginine reference values in healthy subjects whole blood and evaluation of factors affecting protein methylation. Clin Biochem 41: 1218-1223, 2008.
66. Zwickl P, Voges D, Baumeister W. The proteasome: a macromolecular assembly designed for controlled proteolysis. Philos Trans R Soc Lond B Biol Sci 354: 1501-1511, 1999.